Stock listing
Relay Therapeutics, Inc.
Selected listing: RLAY · NASDAQ · USD · US
Relay Therapeutics, Inc. (NASDAQ:RLAY), Health Technology. Latest release Aug 6, 2026: Relay Therapeutics Reports Second Quarter 2026 Financial Results…
- Ticker
- NASDAQ:RLAY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Relay Therapeutics, Inc.
Relay Therapeutics, Inc. is a public company traded under the ticker RLAY in the American market. Relay Therapeutics focuses on advancing drug discovery and development through its innovative approach to protein regulation and targeted therapies.
Latest news from Relay Therapeutics, Inc.
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
August 6, 2026
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
July 30, 2026
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
May 18, 2026
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
May 5, 2026
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
April 29, 2026
Research Relay Therapeutics, Inc.
Relay Therapeutics, Inc. company profile
View the public company page for Relay Therapeutics, Inc. on 6ix.
Relay Therapeutics, Inc. news
Read company news and market updates connected to Relay Therapeutics, Inc..
Relay Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Relay Therapeutics, Inc..